
    
      This is a prospective, multi-center, non-randomized, observational registry of acute ischemic
      stroke patients that have or will undergo treatment with the use of a Covidien
      market-released neurothrombectomy device (as the initial device used to remove the thrombus)
      within 8 hours of stroke symptom onset, at the discretion of the investigator and independent
      of participation in this registry. This registry may enroll up to 1000 patients.
    
  